With more than 40% of US adults, and one in five children, categorized as having obesity, widespread, coordinated action is urgently needed to tackle the obesity epidemic, according to a new report this week.
While interventions should include expanded access to the new class of highly effective weight-loss medications, more challenging structural and environmental changes are needed to prevent the onset of obesity in the first place.
“This is a modern phenomenon,” said Anne Cappola, MD, ScM (Perelman School of Medicine at the University of Pennsylvania, PA). “The genetics have not changed in the past 50 years. It’s the environment, and so if it becomes all about getting greater access to GLP-1 receptor agonists, it’s not really getting at the root problem. It’s helpful for the people that currently have obesity, but it’s doing nothing towards obesity prevention.”
Cappola, the lead author of the new report in JAMA on obesity prevention and care, said the fight to end obesity is an uphill battle against entrenched interests, such as the food industry who profit from the status quo, but change is desperately needed.
“With obesity, at what point is there a decision that the health of this country, and of the world, is important enough that we make changes to the regulation of food to get people healthier,” she told Cardiology Now News. “I think there is this desire to make it better for children, and to make it better for all of us, and that is going to require fighting the food industry in certain ways.”
The new report stems from the JAMA Summit on Obesity, which took place earlier this year, and included representatives from multiple stakeholder groups, such as clinicians, patients, scientists, economists, and policy experts, as well as representatives from government, and the food, wellness, and pharmaceutical industries. Prior summits have focused on clinical trials, guns and injury prevention, and artificial intelligence, and the goal is to put people from different sectors in the room to discuss solutions to large health problems.
The numbers are well known by now. In 2024, according to the World Health Organization (WHO), one in seven, or 1.1 billion people, were living with obesity. In the US, the prevalence of adult obesity is 40.3%, a rate similar in men and women. Globally, the global prevalence of adult obesity has more than doubled since 1990 [cb1] while adolescent obesity has quadrupled. Obesity rates are surging in low- and middle-income countries and the prevalence is highest among people with lower socioeconomic status living in high-income countries.
Some estimates suggest that 20% of healthcare dollars spent go towards obesity-related diseases or conditions, such as type 2 diabetes, cardiovascular disease, liver and kidney disease, and different cancers.
Many Root Causes of Obesity
Class 1 obesity is defined as a body mass index (BMI) of 30 to less than 35 kg/m2 while class 2 obesity is a BMI of 35 to less than 40 kg/m2. Severe obesity, or class 3, is a BMI of ≥ 40 kg/m2 or higher. The causes of obesity are multifactorial and include complex interactions between environmental, social, biological, and behavioral determinants.
This includes everything from a lack of sidewalks in some neighborhoods to changes in US agricultural policy that encouraged greater food production (and larger portion sizes). Proposed restrictions around marketing to children have been defeated by the food industry and there has been an explosion of hyperpalatable, calorically dense, ultraprocessed food available at any time of day or night. Limited access to healthy choices (food deserts), or an inability to afford healthier alternatives, as well as declining physical activity levels or increased leisure time spent online, among other causes, also contribute to the crisis.
“You have a food environment and a physical environment that are conducive to obesity,” said Cappola.
To date, efforts to change the food environment have failed. Initiatives to tamp down the production and marketing of ultraprocessed food have been defeated by food manufacturers, the experts point out. There have been some successes at limiting sugar, salt, and saturated fats, as well as better labeling, but the effects have been modest. Lifestyle interventions designed to improve diet and increase physical activity have not been effective at sustainably decreasing the incidence of obesity.
This is a modern phenomenon. The genetics have not changed in the past 50 years.
Anne Cappola, MD
The introduction of GLP-1 receptor agonists, as well as dual-receptor agonists, has altered the landscape for the medical management of obesity. It’s estimated that one in 10 US adults are taking the medication and experts say the number will grow. WHO added GLP-1 receptor agonists to their essential medicines’ list for diabetes in 2025 and also made formal recommendation for their long-term use in adults with obesity.
Obesity specialists will always be needed to handle the most challenging cases, but primary care doctors, and subspecialists, including cardiologists, should understand how to prescribe the weight-loss medications and know how to connect patients to nutritional support programs, said Cappola.
However, as the experts point out, putting patients on a medication doesn’t address the underlying issues contributing to obesity. Also, these medications are expensive, and patients and clinicians face access hurdles, including insurance coverage barriers or prior authorization requirements.
Equitable access for those from a lower socioeconomic background is also a problem, said Cappola. “Beyond living in this environment that favors obesity, they have less access to the medications that are highly effective in treating obesity,” she said.
Changes in Food Policy
The experts propose a range of ideas to alter the current US food landscape. Federal policy or legislative action is needed to reform agricultural subsidies that encourage the overproduction of food. In the US, caloric availability has climbed and now averages close to 4,000 calories per person per day, which is more than what’s required.
The government could also strengthen regulations over food labeling, product formulation, retail placement, and marketing. Federally funded school nutrition standards are also needed to combat childhood obesity as are restrictions around marketing unhealthy food to children. The government could invest more in supplemental nutrition assistance programs to address health inequities and socioeconomic barriers to healthy food.
In addition, the experts recommend expanding physical activity in schools and communities, improving communication to combat misinformation, strengthening strategies aimed at preventing childhood obesity, expanding and easing access to obesity medications and lifestyle interventions, and advancing obesity science, implementation, and policy evaluation.
“The problem is that it’s not just one single intervention,” said Cappola. “It’s going to require interventions in multiple domains to move the needle. Some things are going to work, and some things aren’t, but to try one approach at a time, that won’t work either. It was not just one problem that got us where we are.”
Importantly, the group also recommend efforts to reduce stigma and bias in obesity care.
“We have to keep reinforcing the message that’s not a lack of willpower,” said Cappola. “This isn’t a problem with personal responsibility. This is an issue where you’re in a very challenging environment, but that is a very hard narrative to change.”
For some people who have felt the stigma or bias at the doctor’s office, they may be reluctant to come in and ask for help to manage their disease, she added. During the JAMA Summit on Obesity, Cappola noted that nutritionist and public health advocate Marion Nestle, MPH, PhD (New York University, NY), reminded the audience to be kind to their patients, something the participants took to heart and emphasized in the report.
Source:
Cappola AR, Angus DC, Ahima RS, et al. Toward a healthier future through obesity prevention and care: the JAMA Summit report on obesity. JAMA. Published online November 17, 2026.
Disclosures:
Cappola reports no conflicts of interest.
